Polyradiculoneuropathy: Clinical Trials

6 trials for Polyradiculoneuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed, 1 not yet recruiting. 6 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 16Recruiting 3, Completed 2, Not yet recruiting 1

Follow Polyradiculoneuropathy: new trials by email Literature Review of Polyradiculoneuropathy trials Research Report on Polyradiculoneuropathy

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
CD19/BCMA-targeted CAR-T cells, Lymphodepleting Conditioning - Relapsing or Refractory Multiple Sclerosis (MS), Myasthenia Gravis (MG)
Early Phase 1RecruitingTongji Hospital362025-12-122026-05-12
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases
UCAR T-cell - Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis
Early Phase 1RecruitingTianjin Huanhu Hospital122025-06-172025-12-15
Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
Universal BCMA CAR-T, Universal CD19 CAR-T, Universal BCMA CAR-T; Universal CD19 CAR-T - Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis, Generalized
Early Phase 1Not yet recruitingXuanwu Hospital, Beijing252025-02-282025-01-01
Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
Virtual Assistant - Stroke, Guillain-Barre Syndrome
Early Phase 1CompletedFundación para la Lucha contra las Enfermedades Neurológicas de la Infancia102023-10-012024-03-28
Effects of Single Plasma Exchange and Double Filtration Plasmapheresis (DFPP) on Peripheral Lymphocyte Phenotypes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Blood sampling - Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Early Phase 1CompletedCentre Hospitalier Universitaire de Nīmes82021-03-122025-12-10
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
CT103A cells, Cyclophosphamide and fludarabine - Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Early Phase 1RecruitingTongji Hospital362020-09-222024-10-30

Narrower conditions

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (5)  ·  Multiple Sclerosis (4)  ·  Myasthenia Gravis (4)  ·  Autoimmune Diseases of the Nervous System (3)  ·  Neuromyelitis Optica (3)  ·  Autoimmune Diseases (1)  ·  Benign Paroxysmal Positional Vertigo (1)  ·  Delirium (1)  ·  Facial Paralysis (1)  ·  Guillain-Barre Syndrome (1)  ·  Meningitis (1)  ·  Migraine Disorders (1)  ·  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (1)  ·  Myositis (1)  ·  POEMS Syndrome (1)

Broader conditions

Chronic Disease (6)  ·  Demyelinating Diseases (6)  ·  Disease Attributes (6)  ·  Immune System Diseases (6)  ·  Nervous System Diseases (6)  ·  Neuromuscular Diseases (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Peripheral Nervous System Diseases (6)  ·  Polyneuropathies (6)  ·  Autoimmune Diseases (5)  ·  Cranial Nerve Diseases (4)  ·  Demyelinating Autoimmune Diseases, CNS (4)  ·  Neoplasms (4)

Interventions

Blood Specimen Collection (1)  ·  Cyclophosphamide (1)  ·  fludarabine (1)

Sponsors

Tongji Hospital (2)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (1)  ·  Tianjin Huanhu Hospital (1)  ·  Xuanwu Hospital, Beijing (1)

Countries

China (4)  ·  Argentina (1)  ·  France (1)

Top investigators

Chuan Qin, Prof. (1)  ·  Daishi Tian, Prof. (1)  ·  Mauricio F Farez, MD MPH (1)  ·  Wei Wang, MD (1)

Results publications

PMID 37658205, PMID 40425008, PMID 41101309